Long-term health effects of e-cigarettes: More research needed

'More research' needed into safety of electronic cigarettes

The need for more research into the long-term health effects of electronic cigarettes has been highlighted by scientists in the British Medical Journal.

Andreas Flouris and Dimitris Oikonomou, from the Institute of Human Performance and Rehabilitation in Greece, are concerned that not enough research has been carried out into the safety - or otherwise - of so-called 'e-cigarettes'.

Their position has been endorsed by Cancer Research UK, which is also concerned by the current lack of information.

E-cigarettes are battery-powered devices that simulate cigarettes by allowing the user to inhale a nicotine vapour.

Sales of the devices are thought to be increasing and a number of celebrities - including Kate Moss and Leonardo DiCaprio - have been spotted using them.

However, few studies have been conducted into the health effects of smoking e-cigarettes and those that have been published have reached differing conclusions.

One, carried out by the US Food and Drug Administration (FDA), found that the amount of nicotine provided with each puff often varies from the amount stated on the label, prompting the agency to express concern about e-cigarettes.

In contrast, a private enterprise called Health New Zealand (HNZ) found that the labelling on e-cigarettes reflected their actual nicotine content.

The FDA's research also detected the presence of diethylene glycol - a highly toxic liquid - in one of the cartridges it investigated, while both the FDA and HNZ found cancer-causing chemicals called tobacco specific N-nitrosamines.

In its report, the FDA suggested that e-cigarettes may therefore be harmful, but HNZ recommended their use as they are likely to be less dangerous than tobacco products.

Meanwhile, a Greek organisation called Demokritos has maintained a neutral stance on the subject after conducting its own research.

Drs Flouris and Oikonomou note that this "represents all the knowledge we currently have about e-cigarettes" and that the European Centre for Disease Prevention and Control is yet to publish any research on the subject.

"Alternative smoking strategies aimed at reducing the threat to public health caused by the tobacco epidemic are always welcome," the researchers conceded.

However, they observed: "To date, our knowledge about the acute and long-term effects of e-cigarette use is, at best, very limited.

"The scarce evidence indicates the existence of various toxic and carcinogenic compounds, albeit in possibly much smaller concentrations than in traditional cigarettes."

Jean King, Cancer Research UK's director of tobacco control, said: "There has been little research into how safe e-cigarettes are. And there's also very little regulation to control these products or their marketing. The only way to be sure of any risks or benefits is through rigorous testing.

"Anyone trying to quit smoking should use medicinal nicotine products such as patches, gum or inhalators, because these have been tested and found to be safe and effective. We believe that e-cigarettes should undergo the same rigorous tests and meet the same standards as all other medicinal products containing nicotine."

Comments

  1. Alex Alex Greece says:

    I am noticing a very negative position to e cig...

    If you say that there are no much reaserch why you dont do more research? simple actions ....

    Dont confuse people by saying only this. Say that its better than regular cigaretes ! Is it 100% better or not? Simple things again....

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk